Contraceptive Technology Update – October 1, 2008
October 1, 2008
View Issues
-
Research eyes male circumcision's impact against HIV acquisition
Just-presented research at the XVII International AIDS Conference in Mexico City indicates that adult male circumcision continues to reduce the risk of acquiring HIV through heterosexual intercourse for at least 3.5 years. -
Use skills training to boost female condom use
While female condoms may be a powerful tool in preventing transmission of sexually transmitted diseases (STDs), women need education to use them effectively. Results from a newly published study indicate that skills training can increase female condom use and the overall level of protected sexual acts. -
Clinic waiting room video reduces new STDs
As you move through your busy day at the clinic, how are you providing important sexually transmitted disease (STD) prevention messages to your patients? If caseload and budgetary restrictions are impeding your intentions, take a look at using a brief waiting room video intervention to complement your efforts. -
New research shows value of family planning
While you might know your work in family planning is important, new research confirms it. Approximately 1.4 million unintended pregnancies and 600,000 abortions are averted each year in the United States each year due to family planning services. -
Washington Watch: Proposed rule expands reach of refusal laws
The Bush administration announced in August that it was introducing a new regulation on the topic of providers' "conscience" or "refusal" rights. -
Council, Segal honored for development efforts
The Population Council, a New York City-based reproductive health research organization, and Sheldon Segal, PhD, distinguished scientist at the council, have been scheduled to receive the 2008 Prix Galien USA Pro Bono Humanum Award for their role in developing implantable hormone delivery systems. -
Be on the lookout for Internet STD drugs
Talk with your patients about fraudulent drugs sold over the Internet as treatment for sexually transmitted diseases (STDs). The Food and Drug Administration (FDA) has issued warning letters to six U.S. companies and one foreign individual for marketing unapproved and misbranded drugs over the Internet to U.S. consumers for STD prevention and treatment. -
STD Quarterly: NIAID will not move forward with HIV vaccine trial — What's next step in vaccine research?
Rewind to 2007. A large HIV vaccine clinical trial sponsored by Merck & Co. is shuttered after an interim analysis concluded that the vaccine did not prevent infection. Fast forward to today. -
STD Quarterly: Simplifying consent eases testing stigma
What is your clinic's policy when it comes to getting a signed informed consent for HIV testing? By eliminating required written consent for HIV testing at the San Francisco Department of Public Health Medical Center, the average monthly rate of HIV tests has increased by 4.38 per 1,000 patient-visits, with a 67% increase (from 8.9 to 14.9) in the monthly average number of new positive HIV tests.